Krystal Biotech Inc (KRYS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $276.36
• Market Cap: $7.97B
• P/E Ratio: 39.90
• EPS: $6.83
• 52-Week High: $298.30
• 52-Week Low: $122.80

Market Sentiment

Krystal Biotech Inc currently has a Bullish sentiment score of 0.27.

About Krystal Biotech Inc

Krystal Biotech, Inc. is a clinical-stage biotechnology company headquartered in Pittsburgh, Pennsylvania, dedicated to developing redosable gene therapies specifically for rare diseases. Leveraging its proprietary platform and robust pipeline, Krystal Biotech aims to deliver sustained therapeutic solutions that significantly improve patient outcomes for genetic disorders. The company's innovative strategies and focused commitment to addressing critical unmet medical needs underscore its pote...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Krystal Biotech Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KRYS pay dividends?

Krystal Biotech Inc (KRYS) does not currently pay a regular dividend.

What is KRYS's P/E ratio?

Krystal Biotech Inc has a price-to-earnings (P/E) ratio of 39.90.

What is KRYS's market cap?

Krystal Biotech Inc (KRYS) has a market capitalization of $7.97B with a current stock price of $276.36.